Editorial
Cardiac troponin I—more than a biomarker for myocardial ischemia?
Abstract
Circulating cardiac troponin (cTn) concentrations have become an increasingly important biomarker for the noninvasive detection of myocardial injury in many cardiovascular diseases, in particular, patients with coronary heart disease presenting with acute chest pain (1).
